Literature DB >> 17445225

The neuroprotective effects of the WldS gene are correlated with proteasome expression rather than apoptosis.

Yannick Simonin1, Marcelino Ferrer-Alcon, Anna Ferri, Ann C Kato.   

Abstract

The Wld(s) gene (slow Wallerian degeneration) specifically delays axonal degeneration following injury and in several models of neurodegenerative diseases. It thus provides an interesting tool to study mechanisms of neurodegeneration. We previously crossed the Wld(s) mice with a mouse mutant that has a motoneuron disease (pmn for progressive motor neuronopathy) and showed that the Wld(s) gene prevented axonal loss, increased the life-span and prolonged the survival of the motoneuron cell bodies. In this study we show that spinal motoneurons of pmn/pmn mice, as opposed to axons, die by apoptosis that cannot be prevented by the Wld(s) gene. However, this same gene could partially rescue the proteasome impairment observed in motoneuron cell bodies and axons of pmn/pmn mice. We conclude that the neuroprotective effect of the Wld(s) gene is not related to an inhibition of apoptosis but could possibly be linked to a regulation in proteasome expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445225     DOI: 10.1111/j.1460-9568.2007.05501.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  3 in total

1.  Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds).

Authors:  Thomas M Wishart; Helen N Pemberton; Sally R James; Chris J McCabe; Thomas H Gillingwater
Journal:  Genome Biol       Date:  2008-06-20       Impact factor: 13.583

2.  Calcium-dependent proteasome activation is required for axonal neurofilament degradation.

Authors:  Joo Youn Park; So Young Jang; Yoon Kyung Shin; Duk Joon Suh; Hwan Tae Park
Journal:  Neural Regen Res       Date:  2013-12-25       Impact factor: 5.135

3.  Proteomic profiling of neuronal mitochondria reveals modulators of synaptic architecture.

Authors:  Laura C Graham; Samantha L Eaton; Paula J Brunton; Abdelmadjid Atrih; Colin Smith; Douglas J Lamont; Thomas H Gillingwater; Giuseppa Pennetta; Paul Skehel; Thomas M Wishart
Journal:  Mol Neurodegener       Date:  2017-10-27       Impact factor: 14.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.